论文部分内容阅读
据Ceccarelli M 2016年1月28日[Cell,2016,164(3):550-563.]报道,对脑神经胶质瘤分子水平全面的理解可以有助于治疗方案的制定及开发新型靶向性治疗方法。当前病理学家主要依赖于在显微镜下肿瘤组织的表象来区分神经胶质瘤是低恶性度还是高恶性度。该方法忽略了样本中的特征性标志,从而导致不合适的治疗。相反,通过观察这种肿瘤组织的分子组成,研究者或许就可以准确预测哪些肿瘤更易于快速
According to Ceccarelli M, January 28, 2016 [Cell, 2016,164 (3): 550-563.] A comprehensive understanding of the molecular level of brain gliomas can contribute to the development of therapeutic regimens and the development of novel targets Sexual treatment. Current pathologists rely mainly on the appearance of the tumor tissue under the microscope to distinguish whether the glioma is low-grade or high-grade. This method ignores the characteristic markers in the sample, resulting in inappropriate treatment. Instead, by looking at the molecular makeup of this tumor, researchers may be able to predict exactly which tumors are more rapid